GHK-Cu (Copper Peptide)

7.2

Strong recommend, BioHarmony verdict

BioHarmony score 7.2 out of 10

GHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5% median closure versus 60.8% vehicle. Systemic injection remains unproven in human trials.

Read full report

What is GHK-Cu (Copper Peptide)?

GHK-Cu is the copper-bound form of the human tripeptide glycyl-L-histidyl-L-lysine. Think of GHK as a small carrier peptide and Cu2+ as the copper ion it holds. Together, GHK-Cu acts less like a stimulant and more like a repair signal: it helps deliver copper into contexts where collagen, elastin, glycosaminoglycans, antioxidant enzymes, keratinocytes, fibroblasts, and wound-bed remodeling are already active.

From the BioHarmony report, reviewed Sep 8, 2026.

Saved on this device only.

Safety watch-outs

  • Injection-site infection
  • Copper excess symptoms: nausea, metallic taste, abdominal pain

Full risk profile in the BioHarmony report.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

No approved-label or study protocol is recorded for GHK-Cu (Copper Peptide) yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Educator coverage (5)

Attributed viewpoints, separate from primary research.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalNot FDA approved
CompoundingInjectable nomination withdrawn from Category 2; eligibility is not established

FDA identifies immunogenicity and peptide-impurity concerns for injectable compounded GHK-Cu and notes that human safety data are limited.

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.